In addition to TB, Fujitaet al. [50] recently reported on three cases of Mycobacterium avium re-activation in lung cancer patients undergoing anti-PD-1 therapy, suggesting that the re-activation mechanism may be conserved across different mycobacterial species. This evidence concerns the gene PDCD1 and lung carcinoma.